Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jonathan L. Yu"'
Autor:
Devin M. Mann, Javier Gonzalez, Jonathan L Yu, Son Luu, Danissa V Rodriguez, Katharine Lawrence, Dawn M Feldthouse
Publikováno v:
J Am Med Inform Assoc
Digital Diabetes Prevention Programs (dDPP) are novel mHealth applications that leverage digital features such as tracking and messaging to support behavior change for diabetes prevention. Despite their clinical effectiveness, long-term engagement to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::031dbd5dc9204c9c9d3805e2f54d0525
https://doi.org/10.1093/jamia/ocab206
https://doi.org/10.1093/jamia/ocab206
Autor:
Ian I. Cardle, Jonathan L. Yu, Nataly Kacherovsky, Suzie H. Pun, Michael L. Baldwin, Stephen J. Salipante, Michael C. Jensen, Emmeline L Cheng
Publikováno v:
Nature Biomedical Engineering. 3:783-795
Chimeric antigen receptor T-cell therapies using defined product compositions require high-purity T-cell isolation systems that, unlike immunomagnetic positive enrichment, are inexpensive and leave no trace on the final cell product. Here, we show th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0244533c7b12f81b74410822e8507204
https://doi.org/10.1038/s41551-019-0411-6
https://doi.org/10.1038/s41551-019-0411-6
Autor:
Lisa L. Groom, Donna Shelley, Hayley M. Belli, Yinxiang Wu, Bonny Rockette-Wagner, Sumaiya Tasneem, Danissa V Rodriguez, Kathleen M. McTigue, Son Luu, Jerlisa Fontaine, Javier Gonzalez, Jonathan L Yu, Devin M. Mann, Katharine Lawrence, Dawn M Feldthouse
Publikováno v:
JMIR Research Protocols, Vol 10, Iss 2, p e26750 (2021)
JMIR Research Protocols
JMIR Research Protocols
Background Digital diabetes prevention programs (dDPPs) are effective behavior change tools to prevent disease progression in patients at risk for diabetes. At present, these programs are poorly integrated into existing health information technology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cbd6e91a223d75b708e1a8e576fff61
http://www.researchprotocols.org/2021/2/e26750/
http://www.researchprotocols.org/2021/2/e26750/
Autor:
Katharine Lawrence, Danissa V Rodriguez, Dawn M Feldthouse, Donna Shelley, Jonathan L Yu, Hayley M Belli, Javier Gonzalez, Sumaiya Tasneem, Jerlisa Fontaine, Lisa L Groom, Son Luu, Yinxiang Wu, Kathleen M McTigue, Bonny Rockette-Wagner, Devin M Mann
BACKGROUND Digital diabetes prevention programs (dDPPs) are effective behavior change tools to prevent disease progression in patients at risk for diabetes. At present, these programs are poorly integrated into existing health information technology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3f51fd5f0bcafb16dec3147d404e8fe
https://doi.org/10.2196/preprints.26750
https://doi.org/10.2196/preprints.26750
Publikováno v:
Journal of Controlled Release. 282:140-147
The clinical success of chimeric antigen receptor (CAR) T cell immunotherapy in treating multiple blood cancers has created a need for efficient methods of ex vivo gene delivery to primary human T cells for cell engineering. Here, we synthesize and e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ed6e9cb2bba1e2d1e8b152db2fcffbe
https://doi.org/10.1016/j.jconrel.2018.02.043
https://doi.org/10.1016/j.jconrel.2018.02.043
Autor:
Nataly, Kacherovsky, Ian I, Cardle, Emmeline L, Cheng, Jonathan L, Yu, Michael L, Baldwin, Stephen J, Salipante, Michael C, Jensen, Suzie H, Pun
Publikováno v:
Nature biomedical engineering
Chimeric antigen receptor (CAR) T-cell therapies using defined product compositions require high-purity T-cell isolation systems that, unlike immunomagnetic positive enrichment, are inexpensive and leave no trace on the final cell product. Here, we s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b3dbaa6a536974ba8e3fb176c7b30d22
https://pubmed.ncbi.nlm.nih.gov/31209354
https://pubmed.ncbi.nlm.nih.gov/31209354
Autor:
Hua Cao, Maja Zavaljevski, Jingjing Tang, André Lieber, Elaine W. Raines, Maryelise Cieslewicz, Suzie H. Pun, Koka Motoyama, Jonathan L. Yu
Publikováno v:
Proceedings of the National Academy of Sciences. 110:15919-15924
Most current cancer therapies focus on killing malignant cells, but these cells are often genetically unstable and can become resistant to chemotherapy. Tumor-associated macrophages (TAMs) facilitate disease progression by promoting angiogenesis and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::290bcc639b4c38989f6492acb4f44e71
https://doi.org/10.1073/pnas.1312197110
https://doi.org/10.1073/pnas.1312197110